Burgeoning biotech demanding more lab space

A growing demand for new biotech and lab space is forcing up rents in the Washington DC area as vacancies decline. Rockville, MD-based Scheer Partners expects vacancies to drop from 8 percent this year to 5 percent next year and three percent the following year. As a result, rents are projected to shoot up from $27 to $36 per square foot. Developers say more speculative lab space is likely to come on the market soon.

"Before, there was a lag period between mature companies and companies still rising," Pete Briskman, a vice president of The Staubach Co., told the Washington Business Journal. "We're seeing that lag being filled now by mid-stage companies."

- read the report on the Washington Business Journal

Suggested Articles

GigaGen joined a group of companies making plasma-based, polyclonal antibody treatments for COVID-19.

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.

Selectively targeting TGF-beta1 with Scholar Rock's SRK-181 overcame primary resistance to checkpoint inhibitor therapy in mice.